|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.66 CNY | -5.03% |
|
-22.68% | -52.36% |
Dali Pharmaceuticalco.,Ltd reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 87.27 million compared to CNY 132.34 million a year ago. Net loss was CNY 20.03 million compared to CNY 17.7 million a year ago.
Basic loss per share from continuing operations was CNY 0.09 compared to CNY 0.08 a year ago. Diluted loss per share from continuing operations was CNY 0.09 compared to CNY 0.08 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -52.36% | 181M | |
| +19.62% | 42.97B | |
| +24.52% | 22.49B | |
| +20.25% | 14.93B | |
| +7.48% | 13.14B | |
| +42.51% | 11.67B | |
| -8.84% | 6.86B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +13.13% | 5.54B |
DALI PHARMACEUTICALCO.,LTD 
